Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing s-adenosyl-l-methionine (SAMe) and a vitamin B complex. SAMe is a naturally occurring compound in the body involved in methylation reactions essential for neurotransmitter synthesis, DNA regulation, and liver function. It has been studied primarily for depression, osteoarthritis, and liver diseases. Vitamin B complex typically includes vitamins such as thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folate (B9), and cobalamin (B12). These vitamins are crucial co-factors in metabolic pathways including those involving SAMe; specifically, vitamins B6, B9, and B12 are required for optimal methylation processes. The combination is often marketed to support mood health, joint comfort, cognitive function, energy metabolism, and liver health. This product is sold as a dietary supplement rather than an approved pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on s-adenosyl-l-methionine + vitamin B complex.